Biotech C4 raids NI­BR for new CMO; EU reg­u­la­tors green­light Hem­li­bra ex­pand­ed la­bel

→ C4 Ther­a­peu­tics has raid­ed the No­var­tis In­sti­tutes of Bio­med­ical Re­search for its chief med­ical of­fi­cer. The biotech re­port­ed to­day that it’s hired on Adam Crys­tal for the spot, fol­low­ing a stint as a se­nior di­rec­tor at NI­BR. C4 is one of sev­er­al biotechs work­ing on pro­tein de­graders, which has al­so been a keen in­ter­est of NI­BR chief Jay Brad­ner. “Dr. Crys­tal’s deep un­der­stand­ing of the sci­ence of tar­get­ed pro­tein degra­da­tion, cou­pled to his proven clin­i­cal lead­er­ship and un­der­stand­ing of the pa­tient com­mu­ni­ty, will be in­stru­men­tal to ad­vanc­ing C4T’s pipeline,” said Andy Phillips, the CEO of C4.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER